Re: Veeru Kasivisvanathan, Vinson Wai-Shun Chan, Keiran D. Clement, et al. An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer. Eur Urol 2025;87:512-23 [0.03%]
关于Kasivisvanathan V, Chan VW, Clement KD等. 系统性经直肠超声检查与MRI目标活检检测前列腺癌的随机对照试验个体患者数据荟萃分析。 Eur Urol 2025;87:512-23
Sherryn Sherryn,Bagus Baskoro,Jie Sun
Sherryn Sherryn
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE Trial [0.03%]
基于系统性和磁共振靶向活检的前列腺癌检测：PROBASE试验比较分析
Rouvier Al-Monajjed,Matthias Boschheidgen,Jale Lakes et al.
Rouvier Al-Monajjed et al.
The optimal approach for prostate cancer (PC) screening, including the ideal starting age and most effective diagnostic method, remains under investigation. We evaluated the diagnostic performance of magnetic resonance imaging (MRI)-targete...
Analysis of gray zone PSA and PSAD correlated with PIRADS v2.1 in the MRI-US fusion prostate biopsy era: a retrospective bi-centre study [0.03%]
基于MRI-US融合靶向活检的PSA灰区分析及其与PIRADS v2.1的相关性研究：一项回顾性的多中心研究
Michelangelo S Cobangbang,Bryian P Paner,Jerome Kyle R San Jose et al.
Michelangelo S Cobangbang et al.
Background: Multiple parameters including PSA, PSAD, and PIRADS v2.1 score, are being associated in an effort to increase the overall detection rate of clinically significant prostate cancer (csPCa). This study aims to ex...
A propensity score-matched analysis on biopsy methods: enhanced detection rates of prostate cancer with combined cognitive fusion-targeted biopsy [0.03%]
倾向匹配评分分析：联合认知融合靶向活检提高前列腺癌的检测率
Bi-Ran Ye,Hui Wang,Yong-Qing Zhang et al.
Bi-Ran Ye et al.
The choice of biopsy method is critical in diagnosing prostate cancer (PCa). This retrospective cohort study compared systematic biopsy (SB) or cognitive fusion-targeted biopsy combined with SB (CB) in detecting PCa and clinically significa...
PSMA-Targeted Biopsy With Fusion Guidance for Detecting Clinically Significant Prostate Cancer in Men With Negative MRI-Feasibility and Diagnostic Performance of a Pilot Single-Center Prospective Study [0.03%]
一项单中心前瞻性研究：使用MRI融合引导的PSMA靶向活检对MRI检查结果为阴性的男性进行具有临床意义的前列腺癌检测的可行性及诊断性能（摘要）
Lorenzo Bianchi,Danilo Cangemi,Andrea Farolfi et al.
Lorenzo Bianchi et al.
Introduction: Contemporary prostate biopsy utilizes multiparametric magnetic resonance (MRI) guidance; however, it may fail to identify a non-negligible proportion of men with clinically significant (csPCa). The main obje...
Incidence, surveillance and natural history of high-grade prostatic epithelial neoplasia in the era of multiparametric MRI and targeted biopsy [0.03%]
多参数MRI和靶向活检时代高级别前列腺上皮内瘤的发病、监测及自然病程
Nathalie Eid,Herbert Lepor
Nathalie Eid
Objectives: To determine the incidence of isolated high grade prostatic epithelial neoplasia (iHGPIN) following magnetic resonance imaging (MRI)-ultrasonography co-registration fusion targeted biopsy (MRFTB) coupled with ...
Transgluteal MRI-targeted biopsy versus transrectal systemic biopsy in prostate cancer diagnosis [0.03%]
经股薄肌MRI目标活检与直肠系统活检在前列腺癌诊断中的比较
Zixi An,Pengyu Sun,Min Liu et al.
Zixi An et al.
Objective: To compare the detection rate of clinically significant prostate cancer (csPCa) between transgluteal in-bore magnetic resonance imaging-targeted biopsy (MRI-TB) and transrectal ultrasonography biopsy (TRUSBx) i...
Risk of Upgrading at Final Pathology after Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsies: A Post Hoc Analysis of the PERFECT Trial [0.03%]
基于PERFECT试验的术后病理升级风险：经会阴与经直肠磁共振靶向活检的回顾性分析
Alessandro Uleri,Eric Barret,Gaëlle Fiard et al.
Alessandro Uleri et al.
Utility of tumor diameter-to-prostate volume ratio for predicting the outcome of magnetic resonance imaging/transrectal ultrasound fusion-targeted biopsy [0.03%]
肿瘤直径与前列腺体积比预测磁共振/经直肠超声融合靶向活检结果的临床价值分析
Yuki Kohada,Shunsuke Miyamoto,Tetsutaro Hayashi et al.
Yuki Kohada et al.
Objectives: To assess the impact of the tumor diameter-to-prostate volume ratio (TD/PV) on predicting prostate cancer (PCa) and clinically significant (cs) -PCa in magnetic resonance imaging (MRI) /transrectal ultrasound ...
耗时 0.14876 秒，为您在
48229835
条记录里面共找到 722 篇文章 [XML]